Collectively, cytosolic HMGB1 acts as a dynamic regulator of pro-survival autophagy in cancer cells exposed to anti-cancer therapies, which may represent a promising vulnerability to restore cancer sensitivity to treatment. Here, HMGB1 is linked to cancer.